StockData
Clearmind Medicine Inc. logo

Clearmind Medicine Inc. (CMND) stock

CMNDNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Score 5/30
$3.06−0.39 (-11.16%)

Close on Nov 18, 2026Market cap $484.50KP/E –Yield –

Clearmind Medicine net income

Net income is the profit left for shareholders after every expense, interest and tax.

No net income figures for Clearmind Medicine

Clearmind Medicine has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Clearmind Medicine figures

See a number that looks wrong?